Evaluation of methods of detecting cell reactive oxygen species production for drug screening and cell cycle studies.
Intracellular reactive oxygen species (ROS) production is essential to normal cell function. However, excessive ROS production causes oxidative damage and cell death. Many pharmacological compounds exert their effects on cell cycle progression by changing intracellular redox state and in many cases cause oxidative damage leading to drug cytotoxicity. Appropriate measurement of intracellular ROS levels during cell cycle progression is therefore crucial in understanding redox-regulation of cell function and drug toxicity and for the development of new drugs. However, due to the extremely short half-life of ROS, measuring the changes in intracellular ROS levels during a particular phase of cell cycle for drug intervention can be challenging. In this article, we have provided updated information on the rationale, the applications, the advantages and limitations of common methods for screening drug effects on intracellular ROS production linked to cell cycle study. Our aim is to facilitate biomedical scientists and researchers in the pharmaceutical industry in choosing or developing specific experimental regimens to suit their research needs.
['Fan|Lampson M|LM|', 'Li|Jian-Mei|JM|']
D002453:Cell Cycle D004353:Drug Evaluation, Preclinical D006207:Half-Life D006801:Humans D010084:Oxidation-Reduction D004364:Pharmaceutical Preparations D017382:Reactive Oxygen Species
Methods Reactive oxygen species Drug screen Cell cycle Cytotoxicity